{
    "organizations": [],
    "uuid": "e710c4eaa702a28ec3ce9935fa93647f141e29ad",
    "author": "",
    "url": "https://www.reuters.com/article/brief-innovate-biopharmaceuticals-expect/brief-innovate-biopharmaceuticals-expects-trading-under-new-ticker-to-begin-on-feb-1-idUSFWN1PQ0YY",
    "ord_in_thread": 0,
    "title": "BRIEF-Innovate Biopharmaceuticals Expects Trading Under New Ticker To Begin On Feb 1",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 31, 2018 / 12:39 PM / in 22 minutes BRIEF-Innovate Biopharmaceuticals Expects Trading Under New Ticker To Begin On Feb 1 Reuters Staff 1 Min Read \nJan 31 (Reuters) - Innovate Biopharmaceuticals Inc: \n* INNOVATE BIOPHARMACEUTICALS ANNOUNCES TRADING UNDER NEW TICKER SYMBOL INNT IS ANTICIPATED TO BEGIN ON THURSDAY, FEBRUARY 1, 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-01-31T14:39:00.000+02:00",
    "crawled": "2018-01-31T15:08:05.006+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "biopharmaceuticals",
        "expects",
        "trading",
        "new",
        "ticker",
        "begin",
        "feb",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "innovate",
        "biopharmaceuticals",
        "inc",
        "innovate",
        "biopharmaceuticals",
        "announces",
        "trading",
        "new",
        "ticker",
        "symbol",
        "innt",
        "anticipated",
        "begin",
        "thursday",
        "february",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}